Skip to content

Clinical trials

Completed Endometrial Neoplasms trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Endometrial Neoplasms Status: Completed Country / region: United States Clear all

291 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20008
200112
20026
20037
200414
20059
200611
200715
200812
20099
201011
201111
201214
201311
201412
20155
201619
201712
201819
201913
202013
20219
20222
20236
20246
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed291

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)29
M.D. Anderson Cancer Center17
Memorial Sloan Kettering Cancer Center16
Gynecologic Oncology Group11
UNC Lineberger Comprehensive Cancer Center9
Ohio State University Comprehensive Cancer Center8
Case Comprehensive Cancer Center7
Duke University5
Masonic Cancer Center, University of Minnesota5
University of Wisconsin, Madison5

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Endometrial Neoplasms291
Uterine Cervical Neoplasms87
Ovarian Neoplasms80
Breast Neoplasms67
Fallopian Tube Neoplasms44
Neoplasms41
Prostatic Neoplasms38
Carcinoma, Non-Small-Cell Lung37
Carcinoma, Ovarian Epithelial37
Pancreatic Neoplasms34

Trials

Showing 1 to 25 of 291. Each trial links to its page on Pharma Observatory.

191 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.